Scancell Holdings Share Price (SCLP)

Victoria Brentville 27/9

Lindy Durrant 26/9

Samantha Paston 26/9

http://www.cancerimmunotherapyconference.org/program-of-events...............IRA MELLMAN PRESENTING

Could well get an RNS this morning re CICON......................Good Morning

Also you said this.................""""And also interestingly the proper first commercial action (Avidimab and the LARGE unnamed pharma) happened after Vulpes involvement, coincidence? Maybe, but Vuples will want to see things get done IMO, and give the BOD a much need kick up the backside...IMO.""

IMHO, IT is no coincidence I have said that many a time, Vulpes would have known of this when they took their stake.

I suspect if Vulpes felt the BOD were................the issue is the boards ineffectiveness/ineptitude/ inability and lack of foresight for getting commercial traction (so far)...again IMO. (p.s. a lack of foresight in general too), they would have run a mile five years ago!!!! It is not a kick up the backside they have paid £4m for, it is for the support to bring home what they have worked so hard on, over years and provide a financial runway to achieve that. AIMHO

Evening, I was trying very hard to find the similiarities in our posts apart from the differences earlier, but feel i want to comment on the body of your post. You posted this...................Yes I can see why you like this comment, and yes it is significant, but it's not in anyway impartial. It's a great soundbite for an AGM......

"""I see you have posted again the Vuples chief technical offer comment "they have not seen anything in the last ten years like our science. Who am I to argue................"

The issue is not the science here at all, i don't think it ever has been IMO, the issue is the boards ineffectiveness/ineptitude/ inability and lack of foresight for getting commercial traction (so far)...again IMO. (p.s. a lack of foresight in general too)

What matters here for pure investors (like me) is deals, up front payments, commercialisation etc."""

Hmmm, where to start? Lets go to the beginning, and Vulpes comment......"""I see you have posted again the Vuples chief technical offer comment "they have not seen anything in the last ten years like our science, to which you reason.......""..Yes I can see why you like this comment, and yes it is significant, but it's not in anyway impartial. It's a great soundbite for an AGM......""" Should the chief medical officer not have mentioned that?? Some statement to make, following up on the five years Vulpes have been researching us before taking their initial stake. Do you doubt they were telling the truth? Any comments made by members of any BOD could be seen as impartial, and I don"t get the cynicism you feel for that at all.

You say and you do say IYHO.............."""The issue is not the science here at all, i don't think it ever has been IMO, the issue is the boards ineffectiveness/ineptitude/ inability and lack of foresight for getting commercial traction (so far)...again IMO. (p.s. a lack of foresight in general too)"""" Very strong words, which I feel is very OTT, we have adapted our mono therapy treatments to be used as combination treatments in Immunodody, gone through exhaustive safety and efficacy profiles, added Amplivant to the mix, participated in Project Blueprint and as you say in a collaboration still with BioNTech and on the Moditope platform and TCRs waiting ready for trials and commercial activity. We have added glycans, mAbs as a third platform which has been developing over the last 5 years, until Scancell were able to announce it, in a market where huge advancements have been going on all around us, does that mean the BOD have.been as you say..........., the issue is the boards ineffectiveness/ineptitude/ inability and lack of foresight for getting commercial traction (so far)...again IMO. (p.s. a lack of foresight in general too). You add ..................¬"".What matters here for pure investors (like me) is deals, up front payments, commercialisation etc."" Well that applies to all of us, am I not a ""pure investor""?? Respect your view, don"t agree

http://www.cancerimmunotherapyconference.org/#program-of-events-1

Crackin, good to see you back, you bought a hefty chunk a while ago??

Thanks for the info re CICON, wasn"t aware that was taking place. WTP, like I say the board were very careful not to get themselves tied up with unrealistic timelines, so as ever news could come at any time, but I rather think the next news will be patients injected, a couple of Patent grants perhaps, and just happy with the knowledge they are working away on all platforms. Catch yer tomorrow guys....................